Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants

Abstract

A combined approach using Tyrer-Cuzick/DR/PRS provides accurate risk stratification, particularly for poor prognosis cancers. This provides support for reducing the screening interval in high-risk women and increasing the screening interval in low-risk women defined by this model.